Achilles Therapeutics (ACHL) Institutional Ownership $1.38 -0.01 (-0.72%) Closing price 02/21/2025 04:00 PM EasternExtended Trading$1.38 0.00 (0.00%) As of 02/21/2025 04:05 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Ownership Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Institutional Ownership Changes (13F Filings) for Achilles Therapeutics (NASDAQ:ACHL)CurrentInstitutional OwnershipPercentage56.38%Number ofInstitutional Buyers(last 12 months)9TotalInstitutional Inflows(last 12 months)$9.73MNumber ofInstitutional Sellers(last 12 months)5TotalInstitutional Outflows(last 12 months)$3.41M Get ACHL Insider Trade Alerts Want to know when executives and insiders are buying or selling Achilles Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address Skip Chart & View Institutional Buying and Selling Data ACHL Institutional Buying and Selling by Quarter Achilles Therapeutics Major Shareholders & Ownership History Export to ExcelReporting DateMajor Shareholder NameShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails2/17/2025 Two Sigma Advisers LP34,200$39K0.0%+52.7%0.083% 2/17/2025 Two Sigma Investments LP61,637$70K0.0%+190.1%0.150% 2/17/2025 BNP Paribas Financial Markets50,189$57K0.0%N/A0.122% 2/13/2025 XTX Topco Ltd26,824$31K0.0%N/A0.065% 2/13/2025 Renaissance Technologies LLC547,233$624K0.0%-14.2%1.331% 11/5/2024 BML Capital Management LLC4,100,002$4.18M2.5%+555.8%9.978% 8/12/2024 XTX Topco Ltd51,660$42K0.0%+239.4%0.126% 8/9/2024 Renaissance Technologies LLC682,734$556K0.0%-32.1%1.662% 8/6/2024 Acadian Asset Management LLC250,825$203K0.0%-10.7%0.610% 5/20/2024 Virtu Financial LLC20,947$26K0.0%-47.1%0.051% Get the Latest News and Ratings for ACHL and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Achilles Therapeutics and its competitors with MarketBeat's FREE daily newsletter. 5/17/2024 Artal Group S.A.755,375$944K0.0%-66.5%1.894% 5/17/2024 Ikarian Capital LLC1,443,181$1.80M0.2%N/A3.619% 5/15/2024 Baker BROS. Advisors LP1,208,775$1.51M0.0%-42.5%3.031% 5/14/2024 StemPoint Capital LP1,385,750$1.73M0.5%N/A3.475% 5/10/2024 Acadian Asset Management LLC280,929$350K0.0%N/A0.704% 3/7/2024 Fcpm Iii Services B.V.2,390,050$2.13M0.6%N/A5.861% 2/14/2024 Vestal Point Capital LP108,083$96K0.0%N/A0.265% 5/12/2023 Forefront Analytics LLC75,625$72K0.0%+147.7%0.185% 2/14/2023 RA Capital Management L.P.1,607,834$1.45M0.0%-67.9%4.107% 11/14/2022 Point72 Asset Management L.P.2,107,595$4.76M0.0%+18.6%5.383% 11/14/2022 Forefront Analytics LLC32,200$72K0.0%N/A0.082% 8/15/2022 Point72 Asset Management L.P.1,776,744$4.48M0.0%+18.4%4.538% 8/15/2022 Kettle Hill Capital Management LLC242,978$612K0.2%N/A0.621% 2/15/2022 Sender Co & Partners Inc.27,690$139K0.1%N/A0.068% 2/14/2022 Point72 Asset Management L.P.1,000,000$5.01M0.0%+100.0%2.463% 2/11/2022 Syncona Portfolio Ltd11,086,909$55.55M53.1%N/A27.306% 11/15/2021 Point72 Asset Management L.P.500,000$3.90M0.0%N/A1.231% 11/15/2021 Sphera Funds Management LTD.242,500$1.89M0.2%-17.0%0.597% 11/15/2021 AXA S.A.279,454$2.18M0.0%+3.8%0.688% 11/15/2021 Farallon Capital Management LLC450,000$3.51M0.0%-54.8%1.108% 11/12/2021 Affinity Asset Advisors LLC100,000$779K0.2%+25.0%0.246% 8/17/2021 Woodline Partners LP77,386$758K0.0%-67.6%0.191% 8/17/2021 Sphera Funds Management LTD.292,194$2.86M0.2%-2.6%0.719% 8/17/2021 Millennium Management LLC196,144$1.92M0.0%-3.3%0.483% 8/16/2021 RA Capital Management L.P.5,014,687$49.09M0.8%+261.1%12.345% 8/16/2021Pinz Capital Management LP16,423$161K0.0%+164.8%0.040% 8/16/2021 Macquarie Group Ltd.40,402$396K0.0%-26.9%0.099% 8/13/2021 Affinity Asset Advisors LLC80,000$783K0.3%+220.0%0.197% 8/13/2021 AXA S.A.269,135$2.64M0.0%N/A0.663% 8/12/2021 JPMorgan Chase & Co.49,405$484K0.0%-92.1%0.122% Ex-CIA Advisor: Trump 2.0 Could “Send Gold to $10,000” (Ad)Experts forecast gold's price racing to $4,000… and an ex-CIA advisor predicts we'll see gold hit $10,000. Should you sit on the sideline while this is happening?That's why we put together a 100% FREE 2025 Gold Guide to show you exactly how to protect and grow y8/12/2021 Monashee Investment Management LLC64,697$633K0.1%-48.2%0.159% 8/6/2021 Sei Investments Co.16,220$159K0.0%N/A0.040% 8/3/2021 Peregrine Capital Management LLC225,669$2.21M0.0%-30.0%0.556% 6/10/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/19/2021 Squarepoint Ops LLC28,000$463K0.0%N/A0.069% 5/18/2021 Baker BROS. Advisors LP2,591,366$42.89M0.2%N/A6.379% 5/18/2021 Millennium Management LLC202,785$3.36M0.0%N/A0.499% 5/18/2021 RA Capital Management L.P.1,388,888$22.99M0.3%N/A3.419% 5/18/2021 Orbimed Advisors LLC1,584,845$26.23M0.2%N/A3.901% 5/18/2021 Redmile Group LLC2,088,089$34.56M0.5%N/A5.140% 5/18/2021 Alyeska Investment Group L.P.32,230$533K0.0%N/A0.079% 5/18/2021 Boxer Capital LLC1,536,208$25.42M0.9%N/A3.782% 5/18/2021 Citadel Advisors LLC39,253$650K0.0%N/A0.097% 5/17/2021 Deerfield Management Company L.P. Series C800,000$13.24M0.3%N/A1.969% 5/17/2021 Perceptive Advisors LLC755,375$12.50M0.2%N/A1.860% 5/17/2021 Woodline Partners LP238,822$3.95M0.1%N/A0.588% 5/17/2021 Caas Capital Management LP50,000$828K0.0%N/A0.123% 5/17/2021Pinz Capital Management LP6,203$103K0.0%N/A0.015% 5/17/2021 Sphera Funds Management LTD.300,000$4.97M0.4%N/A0.739% 5/14/2021 Monashee Investment Management LLC125,000$2.07M0.3%N/A0.308% 5/12/2021 Pura Vida Investments LLC103,026$1.71M0.0%N/A0.254% 5/12/2021 JPMorgan Chase & Co.625,750$10.36M0.0%N/A1.540% 5/11/2021 Peregrine Capital Management LLC322,261$5.33M0.1%N/A0.793% 5/11/2021 Landscape Capital Management L.L.C.12,540$208K0.0%N/A0.031% 5/7/2021BlackRock Inc.25,000$413K0.0%N/A0.062% (Data available from 1/1/2016 forward) ACHL Institutional Ownership - Frequently Asked Questions Who are the largest shareholders of ACHL shares? During the previous two years, 15 institutional investors and hedge funds held shares of Achilles Therapeutics. The most heavily invested institutionals were BML Capital Management LLC ($4.18M), Fcpm Iii Services B.V. ($2.13M), Ikarian Capital LLC ($1.80M), StemPoint Capital LP ($1.73M), Baker BROS. Advisors LP ($1.51M), Artal Group S.A. ($944K), and Renaissance Technologies LLC ($624K).Learn more on ACHL's institutional investors. What percentage of Achilles Therapeutics stock is owned by institutional investors? 56.38% of Achilles Therapeutics stock is owned by institutional investors. Learn more on ACHL's institutional investor holdings. Which institutional investors have been buying Achilles Therapeutics stock? Of the 11 institutional investors that purchased Achilles Therapeutics stock in the last 24 months, the following investors and hedge funds have bought the highest volume of shares: BML Capital Management LLC ($3.47M), Fcpm Iii Services B.V. ($2.39M), Ikarian Capital LLC ($1.44M), StemPoint Capital LP ($1.39M), Acadian Asset Management LLC ($280.93K), Vestal Point Capital LP ($108.08K), and XTX Topco Ltd ($63.27K). How much institutional buying is happening at Achilles Therapeutics? Institutional investors have bought a total of 9,293,563 shares in the last 24 months. This purchase volume represents approximately $9.87M in transactions. Which Achilles Therapeutics major shareholders have been selling company stock? The following institutional investors have sold Achilles Therapeutics stock in the last 24 months: Artal Group S.A. ($1.50M), Baker BROS. Advisors LP ($894.02K), Renaissance Technologies LLC ($413.93K), Acadian Asset Management LLC ($30.10K), and Virtu Financial LLC ($18.65K). How much institutional selling is happening at Achilles Therapeutics? Institutional investors have sold a total of 2,856,692 shares in the last 24 months. This volume of shares sold represents approximately $3.41M in transactions. Related Companies ALMS Major Shareholders OGI Major Shareholders LFCR Major Shareholders CGEN Major Shareholders LRMR Major Shareholders AMRN Major Shareholders CTNM Major Shareholders DRUG Major Shareholders SLRN Major Shareholders OCGN Major Shareholders This page (NASDAQ:ACHL) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersWhat is this southern state hiding?The financial press had a field day this week after President Donald Trump and Department of Government Effici...Stansberry Research | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredElon Takes Aim at Social SecurityElon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Achilles Therapeutics plc Please log in to your account or sign up in order to add this asset to your watchlist. Share Achilles Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free ACHL Stock Alerts